Viridian Therapeutics (VRDN) Q3 2025 Earnings

Aug 6Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.15
-1.04
-0.92
-0.81

Details

Expected EPS
-1.00924
Actual EPS
-1
Surprise EPS
0.01
Surprise Percent
+0.92%

Description

⁨Viridian Therapeutics⁩ (⁦VRDN⁩) has reported earnings of ⁦-1⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts